The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the ...

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

A University of Chicago trial is drawing attention for a type 1 diabetes treatment that moved fast. New findings say all 10 ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can dramatically quell their compulsive behaviors—including cravings for alcohol ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified for GLP-1 treatment had a higher risk of type 2 diabetes, suggesting that ...

Alcohol and Weight Loss Medications This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA It’s normal to have lots ...